December 3, 2018

Planned Phase 2 Trial to Test Vaccine in Triple-negative Breast Cancer Patients, Generex Says

News

Generex Biotechnology has entered into an agreement with the NSABP Foundation to manage a possible Phase 2 clinical trial testing an anti-cancer vaccine in patients with metastatic triple negative breast cancer. ... Read more

November 17, 2014October 18, 2016

Antibody Response to Generex’s AE37 Breast Cancer Vaccine Allows Reduced Relapse

Breast Cancer News, News

At the 29th Annual Meeting & Associated Programs of the Society for Immunotherapy of Cancer held November 6-9, a representative from Generex Biotechnology Corporation presented data detailing proof of concept ... Read more